中国心脏康复的发展:现状和未来前景
1Rehabilitation Medical Center, Beijing Jingmei Group General Hospital, 102300 Beijing, China.
Reviews in cardiovascular medicine
|August 14, 2024
概括
中国的心脏康复已经取得了重大进展,改善了患者的健康状况,降低了心血管疾病的风险. 这篇评论详细介绍了它的发展,实践和研究,为全球理解提供了见解.
科学领域:
- 心血管医学 心血管医学
- 康复医学 康复医学 康复医学
- 预防性心脏病学 预防性心脏病学
背景情况:
- 中国日益增长的意识突出了心脏康复对心血管疾病二次预防的好处.
- 心脏康复是一种多学科的方法,涉及心脏病学,体育医学,康复,营养和心理学.
- 系统的心脏康复可以改善身体和精神健康,降低心血管患者的死亡率和复发风险.
研究的目的:
- 提供关于中国心脏康复的概述,包括其历史,临床实践和研究.
- 专注于中国心脏康复的当前临床模式和研究成果.
- 提供关于中国心脏康复及其未来前景的国际视角.
主要方法:
- 审查中国心脏康复的历史发展和当前临床实践模式.
- 分析最新的临床研究发现和结果.
- 对国际谅解领域的系统视角.
主要成果:
- 由于公众,学术界和政府意识的提高,中国心脏康复领域取得了重大进展.
- 确立的临床实践模式和积极的研究,有助于患者的康复和疾病预防.
- 标准化心脏康复在改善患者结果方面已证明有效.
结论:
- 中国的心脏康复是一个快速发展的多学科领域,为心血管疾病患者带来了巨大的好处.
- 该综述提供了对中国当前心脏康复环境的全面了解.
- 未来的前景表明,基于证据的实践在心脏康复中继续增长和整合.
相关概念视频
Coronary Artery Disease V: Interprofessional Care
444
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Heart Failure VI: Adjunct Therapies
632
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
632
Cardiomyopathy II: Dilated Cardiomyopathy
790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Cardiomyopathy III: Hypertrophic Cardiomyopathy
805
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Cardiomyopathy V: Interprofessional Care
753
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
Cardiomyopathy VI: Nursing Management
481
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
481


